Next Generation Sequencing to Determine the Cystic Fibrosis Mutation Spectrum in Palestinian Population

od Essawi, O., Farraj, M., De Leeneer, K., Steyaert, W., De Pauw, K., De Paepe, A., Claes, K., Essawi, T., Coucke, P. J.
Wydane w Dis Markers (2015)

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

od Osher, D J, De Leeneer, K, Michils, G, Hamel, N, Tomiak, E, Poppe, B, Leunen, K, Legius, E, Shuen, A, Smith, E, Arseneau, J, Tonin, P, Matthijs, G, Claes, K, Tischkowitz, M D, Foulkes, W D
Wydane 2012

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

od Francies, F. Z., Wainstein, T., De Leeneer, K., Cairns, A., Murdoch, M., Nietz, S., Cubasch, H., Poppe, B., Van Maerken, T., Crombez, B., Coene, I., Kerr, R., Slabbert, J. P., Vral, A., Krause, A., Baeyens, A., Claes, K. B. M.
Wydane w BMC Cancer (2015)

Breast-Cancer Risk in Families with Mutations in PALB2

od Antoniou, A.C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., Tomiak, E., Neuhausen, S.L., Teo, Z.L., Khan, S., Aittomäki, K., Moilanen, J.S., Turnbull, C., Seal, S., Mannermaa, A., Kallioniemi, A., Lindeman, G.J., Buys, S.S., Andrulis, I.L., Radice, P., Tondini, C., Manoukian, S., Toland, A.E., Miron, P., Weitzel, J.N., Domchek, S.M., Poppe, B., Claes, K.B.M., Yannoukakos, D., Concannon, P., Bernstein, J.L., James, P.A., Easton, D.F., Goldgar, D.E., Hopper, J.L., Rahman, N., Peterlongo, P., Nevanlinna, H., King, M.-C., Couch, F.J., Southey, M.C., Winqvist, R., Foulkes, W.D., Tischkowitz, M.
Wydane 2014